NIHR Biomedical Research Centres (BRC): Government against COVID-19 Funding Support
Entity: NIHR Biomedical Research Centres (BRC)
Category: Funding support
Description: The NIHR Oxford Biomedical Research Centre (BRC) has allocated funding to COVID-19 research projects in an attempt to improve treatment, understand how the virus interacts with chronic diseases, and the longer-term effects of infection on organs.
The funding, originally earmarked for BRC cross-theme cluster projects, has been diverted to research projects in the BRC’s Respiratory, Technology and Digital Health, and Imaging themes.
1. Project: Chronic Conditions. A project jointly led by Prof Peter Watkinson of the Nuffield Department of Clinical Neurosciences and Professor Julia Hippisley-Cox of the Nuffield Department of Primary Care Health Sciences, will use national QResearch-Oxford record linkage study to understand whether drugs commonly taken for chronic conditions such as hypertension or diabetes may exacerbate or reduce the severity of COVID-19 disease.
+ Beneficiaries
. Nuffield Department of Clinical Neurosciences
. Nuffield Department of Primary Care Health Sciences
Category: Funding support
Description: The NIHR Oxford Biomedical Research Centre (BRC) has allocated funding to COVID-19 research projects in an attempt to improve treatment, understand how the virus interacts with chronic diseases, and the longer-term effects of infection on organs.
The funding, originally earmarked for BRC cross-theme cluster projects, has been diverted to research projects in the BRC’s Respiratory, Technology and Digital Health, and Imaging themes.
1. Project: Chronic Conditions. A project jointly led by Prof Peter Watkinson of the Nuffield Department of Clinical Neurosciences and Professor Julia Hippisley-Cox of the Nuffield Department of Primary Care Health Sciences, will use national QResearch-Oxford record linkage study to understand whether drugs commonly taken for chronic conditions such as hypertension or diabetes may exacerbate or reduce the severity of COVID-19 disease.
+ Beneficiaries
. Nuffield Department of Clinical Neurosciences
. Nuffield Department of Primary Care Health Sciences
Technology:
COVID UK Funding&Support
Industry:
COVID UK Government
Headquarters:
United Kingdom
Founded Date:
N/A
Employees Number:
N/A
Funding Status:
N/A
Investor Type:
N/A
Investment Stage:
N/A
Number Of Exits:
N/A
Register and Claim Ownership